Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.

Hepatitis Awareness Month --- May 2010

May 2010 marks the 15th anniversary of Hepatitis Awareness Month in the United States, and May 19 is World Hepatitis Day. Globally, viral hepatitis is the cause of most (78%) primary liver cancer, the third leading cause of cancer deaths in the world (1). Prevention of hepatitis B and hepatitis C virus transmission and treatment for early disease can prevent primary liver cancer (2). This issue of MMWR includes a report describing vaccination of at-risk adults with hepatitis B vaccine in California and a report on continued increases in hepatocellular carcinoma incidence in the United States.

The Institute of Medicine (IOM) recently issued Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and Hepatitis C. The IOM strategy has four components: 1) accurate public health surveillance, 2) innovative approaches to community education, 3) immunization capacity to eliminate hepatitis B virus transmission, and 4) development of viral hepatitis services, including screening with referral for medical management. Taken together, these strategies can reduce morbidity associated with viral hepatitis, including primary liver cancer.

Additional information about viral hepatitis is available at http://www.cdc.gov/hepatitis. The IOM report is available at http://www.iom.edu. Information about World Hepatitis Day activities is available at http://www.nvhr.org/WHD-2009.htm.

References

  1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74--108.
  2. Cardoso AC, Moucari R, Figueiredo-Mendes C, et al. Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis. J Hepatol 2010;52:652--7.


Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.


All MMWR HTML versions of articles are electronic conversions from typeset documents. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

 
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #